Our results revealed that low expression in ESCC is associated with worse outcomes, and NUF2 can efficiently distinguish tumor tissues from normal tissue (AUC= 99.2%), suggesting its diagnostic value for ESCC. This evidence concerns the gene NUF2 and neoplasm.